20 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's Session

Gainers

• China SXT Pharmaceuticals, Inc. SXTC stock rose 24.9% to $1.11 during Monday's regular session.

• Myos Rens Technology, Inc. MYOS stock moved upwards by 9.7% to $1.47.

• Dr Reddy's Laboratories, Inc. RDY shares moved upwards by 5.3% to $44.19. According to the most recent rating by Citigroup, on January 09, the current rating is at Buy.

• Spherix, Inc. SPEX shares surged 4.4% to $1.19.

• Neoleukin Therapeutics, Inc. NLTX shares surged 4.0% to $11.03. The most recent rating by Piper Sandler, on January 10, is at Overweight, with a price target of $20.00.

• Rockwell Medical, Inc. RMTI stock moved upwards by 3.5% to $2.66. The most recent rating by Piper Jaffray, on November 12, is at Overweight, with a price target of $6.00.

• Relmada Therapeutics, Inc. RLMD shares increased by 3.3% to $44.71. The most recent rating by Jefferies, on January 27, is at Buy, with a price target of $75.00.

Losers

• FSD Pharma, Inc. HUGE stock decreased by 8.6% to $5.82 during Monday's regular session.

• Aphria, Inc. APHA shares plummeted 5.5% to $4.98. According to the most recent rating by CiBC, on January 15, the current rating is at Neutral.

• Sundial Growers, Inc. SNDL shares plummeted 5.2% to $2.49. The most recent rating by BMO Capital, on October 31, is at Market Perform, with a price target of $4.00.

• Mallinckrodt, Inc. MNK shares decreased by 4.6% to $4.93.

• Lipocine, Inc. LPCN shares plummeted 4.0% to $0.45.

• Veru, Inc. VERU stock declined 4.0% to $3.59. The most recent rating by H.C. Wainwright, on January 21, is at Buy, with a price target of $6.00.

• Guardion Health Sciences, Inc. GHSI stock fell 4.0% to $0.30.

• Avadel Pharmaceuticals, Inc. AVDL stock plummeted 3.9% to $6.62.

• Tilray, Inc. TLRY shares fell 3.7% to $19.02. The most recent rating by B of A Securities, on January 13, is at Neutral, with a price target of $18.00.

• Alimera Sciences, Inc. ALIM shares declined 3.5% to $7.09. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $15.00.

• Durect, Inc. DRRX stock fell 3.5% to $1.93. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.

• OrganiGram Holdings, Inc. OGI shares fell 3.4% to $2.67. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.

• Correvio Pharma, Inc. CORV shares fell 3.1% to $0.35. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.